Shri Ahimsa Naturals Limited (NSE:SHRIAHIMSA)

Market Cap	4.38B
Revenue (ttm)	779.77M
Net Income (ttm)	186.67M
Shares Out	23.33M
EPS (ttm)	10.19
PE Ratio	18.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,200
Average Volume	79,920
Open	202.00
Previous Close	199.65
Day's Range	199.85 - 205.90
52-Week Range	126.50 - 214.90
Beta	n/a
RSI	59.07
Earnings Date	n/a

About Sage Therapeutics

Shri Ahimsa Naturals Limited engages in the extraction, manufacturing, and sale of caffeine anhydrous natural, green coffee bean extracts, and crude caffeine in India and internationally. Its products are used in food and beverage, nutraceuticals, cosmetics, and pharmaceutical industries. The company also trades in herbal extracts products, such as senna leaf powdered extract, ashwagandha extract, turmeric extract curcumin, garcinia cambogia powdered extract, and bacopa monnieri powdered extract. It also exports its products to the United State...

• Industry: Miscellaneous Food Preparations And Kindred Products
• Founded: 1990
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SHRIAHIMSA

Financial Performance

In 2023, Shri Ahimsa Naturals's revenue was 779.77 million, a decrease of -24.94% compared to the previous year's 1.04 billion. Earnings were 186.67 million, a decrease of -51.14%.

Financial numbers in IDR